The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
11 | 5 | 10 | 17 |
Growth
|
93 | 99 | 97 | 87 |
Safety
|
11 | 11 | 83 | 83 |
Sentiment
|
39 | 81 | 66 | 54 |
|
50 | 50 | 78 | 62 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
3 | 5 | 15 | 13 |
Opinions Change
|
63 | 91 | 40 | 50 |
Pro Holdings
|
n/a | 83 | 84 | 42 |
Market Pulse
|
82 | 82 | 89 | 90 |
Sentiment
|
39 | 81 | 66 | 54 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
11 | 5 | 10 | 17 |
Growth
|
93 | 99 | 97 | 87 |
|
11 | 11 | 83 | 83 |
Combined
|
18 | 18 | 86 | 86 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
5 | 3 | 10 | 14 |
Price vs. Earnings (P/E)
|
1 | 1 | 1 | 2 |
Price vs. Book (P/B)
|
1 | 1 | 1 | 3 |
Dividend Yield
|
55 | 48 | 57 | 64 |
Value
|
11 | 5 | 10 | 17 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
94 | 96 | 81 | 46 |
Profit Growth
|
67 | 64 | 60 | 62 |
Capital Growth
|
61 | 65 | 89 | 94 |
Stock Returns
|
95 | 99 | 87 | 81 |
Growth
|
93 | 99 | 97 | 87 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
87 | 91 | 89 | 73 |
Refinancing
|
10 | 17 | 11 | 11 |
Liquidity
|
15 | 15 | 91 | 91 |
|
11 | 11 | 83 | 83 |
Discover high‑ranked alternatives to Pro Medicus and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.